Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 671

1.

Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence.

Lord RV, Salonga D, Danenberg KD, Peters JH, DeMeester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, DeMeester SR, Bremner CG, Tsai PI, Danenberg PV.

J Gastrointest Surg. 2000 Mar-Apr;4(2):135-42.

PMID:
10675236
2.

Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Park JM, Salonga D, Groshen S, Tsao-Wei DD, DeMeester TR, Hölscher AH, Danenberg PV.

J Surg Res. 2001 Aug;99(2):301-6.

PMID:
11469901
3.

Telomerase, hTERT and splice variants in Barrett's oesophagus and oesophageal adenocarcinoma.

Barclay JY, Morris A, Nwokolo CU.

Eur J Gastroenterol Hepatol. 2005 Feb;17(2):221-7.

PMID:
15674101
4.

Glutathione S-transferase-pi expression is downregulated in patients with Barrett's esophagus and esophageal adenocarcinoma.

Brabender J, Lord RV, Wickramasinghe K, Metzger R, Schneider PM, Park JM, Hölscher AH, DeMeester TR, Danenberg KD, Danenberg PV.

J Gastrointest Surg. 2002 May-Jun;6(3):359-67.

PMID:
12022988
5.

Role of retinoid X receptor mRNA expression in Barrett's esophagus.

Brabender J, Lord RV, Metzger R, Park J, Salonga D, Danenberg KD, Hölscher AH, Danenberg PV, Schneider PM.

J Gastrointest Surg. 2004 May-Jun;8(4):413-22.

PMID:
15120365
6.

Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Brabender J, Lord RV, Danenberg KD, Metzger R, Schneider PM, Uetake H, Kawakami K, Park JM, Salonga D, Peters JH, DeMeester TR, Hölscher AH, Danenberg PV.

J Gastrointest Surg. 2001 Mar-Apr;5(2):174-81; discussion 182.

PMID:
11331481
7.

Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.

Lord RV, Park JM, Wickramasinghe K, DeMeester SR, Oberg S, Salonga D, Singer J, Peters JH, Danenberg KD, Demeester TR, Danenberg PV.

J Thorac Cardiovasc Surg. 2003 Feb;125(2):246-53.

8.

Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.

Wu GD, Beer DG, Moore JH, Orringer MB, Appelman HD, Traber PG.

Gastroenterology. 1993 Sep;105(3):837-44.

PMID:
8359653
9.

A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.

Brabender J, Marjoram P, Salonga D, Metzger R, Schneider PM, Park JM, Schneider S, Hölscher AH, Yin J, Meltzer SJ, Danenberg KD, Danenberg PV, Lord RV.

Oncogene. 2004 Jun 10;23(27):4780-8.

PMID:
15107828
10.

Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.

Vallböhmer D, Peters JH, Oh D, Kuramochi H, Shimizu D, Demeester SR, Hagen JA, Chandrasoma PT, Danenberg KD, DeMeester TR, Danenberg P.

Surgery. 2005 Oct;138(4):701-6; discussion 706-7.

PMID:
16269299
11.

Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.

Yu HP, Xu SQ, Lu WH, Li YY, Li F, Wang XL, Su YH.

J Surg Oncol. 2004 May 1;86(2):99-104.

PMID:
15112252
12.

Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.

Kimchi ET, Posner MC, Park JO, Darga TE, Kocherginsky M, Karrison T, Hart J, Smith KD, Mezhir JJ, Weichselbaum RR, Khodarev NN.

Cancer Res. 2005 Apr 15;65(8):3146-54.

13.

The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.

Brabender J, Marjoram P, Lord RV, Metzger R, Salonga D, Vallböhmer D, Schäfer H, Danenberg KD, Danenberg PV, Selaru FM, Baldus SE, Hölscher AH, Meltzer SJ, Schneider PM.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2113-7.

14.

Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.

O'Riordan JM, Abdel-latif MM, Ravi N, McNamara D, Byrne PJ, McDonald GS, Keeling PW, Kelleher D, Reynolds JV.

Am J Gastroenterol. 2005 Jun;100(6):1257-64.

PMID:
15929754
16.

Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.

Lord RV, Brabender J, Wickramasinghe K, DeMeester SR, Holscher A, Schneider PM, Danenberg PV, DeMeester TR.

Surgery. 2005 Nov;138(5):924-31.

PMID:
16291394
17.
18.

Expression of C1q complement component in Barrett's esophagus and esophageal adenocarcinoma.

Bobryshev YV, Lu J, Lord RV.

J Gastrointest Surg. 2010 Aug;14(8):1207-13. doi: 10.1007/s11605-010-1230-y. Epub 2010 May 22.

PMID:
20496011
19.

Preferential up-regulation of heparanase and cyclooxygenase-2 in carcinogenesis of Barrett's oesophagus and intestinal-type gastric carcinoma.

Sonoda R, Naomoto Y, Shirakawa Y, Fujiwara Y, Yamatsuji T, Noma K, Tanabe S, Takaoka M, Gunduz M, Tsujigiwa H, Nagatsuka H, Ohara N, Yoshino T, Takubo K, Vieth M, Tanaka N.

Histopathology. 2010 Jul;57(1):90-100. doi: 10.1111/j.1365-2559.2010.03594.x.

PMID:
20653782
20.

Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus.

Hennig EE, Mikula M, Orlowska J, Jarosz D, Bielasik A, Regula J, Ostrowski J.

J Mol Med (Berl). 2008 Feb;86(2):233-42. Epub 2007 Oct 19.

PMID:
17952395

Supplemental Content

Support Center